human
enteroviru
ev
belong
picornaviru
famili
consist
medic
relev
virus
peptidomimet
inhibitor
develop
inhibit
proteas
rhinoviru
member
famili
chymotrypsinlik
proteas
requir
viral
replic
form
coval
bond
activ
site
cy
residu
studi
prepar
recombin
proteas
particular
strain
caus
sever
outbreak
asia
develop
inhibitor
proteas
viral
replic
inhibitor
design
group
interact
rhinoviru
proteas
replac
seri
cinnamoyl
deriv
directli
link
group
amid
bond
simplifi
synthesi
replac
caus
decreas
potenc
activ
larg
improv
substitut
bunsatur
ester
aldehyd
posit
best
inhibitor
show
ec
nm
without
appar
toxic
cc
lm
studi
provid
potent
inhibitor
proteas
agent
facilit
combinatori
synthesi
deriv
improv
inhibitori
activ
enteroviru
ev
member
picornavirida
famili
primari
caus
agent
hand
foot
mouth
diseas
human
anim
sever
case
ev
damag
central
nervou
system
lead
viral
mening
enceph
sever
myocard
well
fatal
pulmonari
edema
children
particularli
vulner
due
rel
immunodefici
billion
case
ev
infect
annual
worldwid
sever
outbreak
report
sever
outbreak
occur
taiwan
caus
case
infect
children
death
sinc
steadi
number
case
caus
particular
ev
strain
report
annual
may
chines
health
author
report
major
outbreak
anhui
provinc
china
led
death
may
date
effect
antivir
therapi
diseas
caus
ev
avail
like
picornavirus
poliovirus
rhinovirus
rv
coxsackievirus
hepat
virus
viral
encod
chymotrypsinlik
proteas
proteas
requir
proteolyt
process
larg
polyprotein
translat
viral
rna
genom
thu
essenti
viral
replic
rv
proteas
use
target
develop
inhibitor
aim
treat
common
cold
peptidomimet
inhibitor
see
structur
contain
lactam
ring
mimic
gln
posit
fluorophenylalanin
val
follow
bunsatur
ester
michael
acceptor
form
coval
bond
activ
site
cy
residu
recent
research
shown
effect
ec
nm
respect
like
due
structur
similar
proteas
judg
sequenc
homolog
provid
start
point
develop
potent
inhibitor
studi
express
purifi
character
recombin
proteas
develop
fluorescencebas
enzymat
assay
accord
substrat
specif
base
crystal
structur
rv
proteas
complex
design
synthes
new
compound
evalu
inhibitori
activ
enzymat
cellbas
assay
find
serv
basi
drug
develop
proteas
express
vector
contain
ctermin
hexahistag
form
purifi
use
ninta
column
order
observ
effect
addit
residu
hexahi
proteas
activ
also
express
proteas
without
tag
purifi
use
cationexchang
column
follow
sizeexclus
column
three
form
protein
purifi
homogen
shown
sdspage
fig
yield
nand
ctermin
histag
form
higher
mgl
medium
respect
tagfre
proteas
mgl
medium
three
form
proteas
compar
activ
use
fluorescencebas
assay
describ
found
proteas
cterminu
histag
specif
activ
equal
tagfre
enzym
enzym
ntermin
histag
display
lower
activ
indic
addit
ntermin
amino
acid
interf
proteas
activ
thu
use
proteas
ctermin
histag
follow
studi
peptid
correspond
autoprocess
site
proteas
includ
rqavtq
gfptel
qtgtiq
gdrvad
deameq
gvsdyi
iealfq
gppkfr
rtatvq
gpsldf
yfcseq
geiqwn
tsavlq
sgfrkm
deriv
ntermin
autoprocess
site
proteas
sever
acut
respiratori
syndromecoronaviru
sarscov
contain
gln
follow
small
amino
acid
ser
gli
serv
cleavag
site
test
substrat
proteas
indic
cleavag
site
surprisingli
proteas
show
substanti
better
activ
tsavlq
sgfrkm
substrat
sarscov
proteas
aganist
cleavag
site
base
hplc
assay
fig
therefor
peptid
dabcylktsavlqsgfrkmeedan
fluoresc
quench
pair
dabcyledan
chosen
proteas
assay
monitor
fluoresc
increas
due
peptid
bond
cleavag
real
time
k
k
cat
enzym
use
fluorogen
substrat
measur
lm
min
respect
fig
use
intermedi
synthes
start
materi
make
new
analogu
fig
modifi
report
method
protect
group
tertbutyloxycarboni
boc
remov
result
speci
react
bocprotect
phe
make
molecul
contain
ring
bunsatur
ethyl
ester
simplifi
synthesi
varieti
differ
acyl
chlorid
coupl
amid
bond
make
librari
compound
among
found
best
inhibit
came
compound
deriv
cinnamoyl
chlorid
illustr
figur
cinnamoyl
chlorid
substitu
methylenedioxi
h
benzen
ring
respect
incorpor
make
make
analogu
contain
aldehyd
posit
condens
benzyloxycarbonyl
cbz
protect
phe
make
fig
methyl
ester
convert
aldehyd
make
ad
cinnamoyl
chlorid
methyl
ester
form
compound
synthes
reduct
follow
oxid
methyl
ester
recombin
proteas
fluorogen
substrat
use
evalu
ic
synthes
compound
compound
basic
featur
ring
bunsatur
ester
inhibit
enzym
lm
greatest
concentr
test
addit
cinnamoyl
group
show
smaller
ic
valu
lm
enzym
respect
preincub
proteas
tabl
howev
timedepend
inhibit
observ
prolong
time
window
exampl
fig
top
panel
replot
fig
lower
panel
k
inact
calcul
min
k
lm
agreement
k
valu
show
ec
lm
respect
antivir
assay
howev
display
cellular
toxic
cc
lm
respect
replac
bunsatur
ester
aldehyd
posit
display
smaller
ec
valu
compar
tabl
display
potent
inhibitori
activ
ec
nm
respect
without
cytotox
concentr
approxim
greater
ec
antivir
activ
demonstr
use
western
blot
analysi
shown
figur
ration
differ
inhibitori
activ
compound
comput
program
use
dock
cyan
yellow
salmon
activ
site
proteas
structur
simul
use
structur
rv
proteas
templat
comput
model
fig
found
order
accommod
bunsatur
ester
poor
inhibitor
site
cinnamoyl
group
forc
away
site
see
top
view
left
panel
side
view
right
panel
could
make
proper
interact
nearbi
amino
acid
eg
lead
signific
loss
bind
affin
inhibitori
activ
howev
aldehyd
much
smaller
size
potent
inhibitor
bind
becom
favor
aldehyd
group
occupi
similar
posit
acarbon
activ
site
readili
access
nucleophil
show
purifi
protein
without
tag
ntermin
histag
ctermin
histag
respect
b
compar
peptid
deriv
autoactiv
site
proteas
show
best
activ
toward
prefer
substrat
tsavlqsgfrkm
sarscov
proteas
c
use
peptid
contain
fluoresc
quench
pair
initi
rate
proteas
versu
substrat
concentr
measur
obtain
k
cat
min
k
lm
studi
verifi
proteas
target
antiev
drug
discoveri
base
enzymeand
cellbas
assay
compound
inhibit
proteas
activ
also
block
viral
replic
cellbas
assay
similar
activ
order
set
assay
find
proteas
inhibitor
express
purifi
character
recombin
proteas
test
potenti
substrat
unexpectedli
found
proteas
show
best
activ
ho
c
co
h
nh
substrat
peptid
deriv
ntermin
autocleavag
site
sarscov
proteas
use
fluorogen
peptid
evalu
seri
analogu
inhibitor
proteas
test
antivir
activ
compar
complic
procedur
synthes
requir
synthesi
assembl
three
moieti
report
potent
analogu
easili
synthes
use
agent
studi
contrast
tripeptid
aldehyd
inhibitor
rv
proteas
contain
gln
unnatur
amino
acid
phe
cbzleu
posit
show
moder
ec
lm
rang
lactam
ring
posit
phe
cinnamoyl
deriv
aldehyd
exhibit
great
inhibitori
activ
enzymat
antivir
assay
without
cytotox
therefor
group
import
leu
val
posit
seem
import
antiviru
activ
howev
bunsatur
ester
key
featur
guarante
proteasebind
affin
enzym
inhibit
found
compound
lm
addit
cinnamoyl
group
simultan
replac
bunsatur
ester
aldehyd
yield
potent
inhibit
ration
comput
model
aldehyd
group
form
revers
coval
bond
catalyt
cy
import
inhibit
sinc
compound
ch
oh
co
effect
inhibit
proteas
studi
provid
potent
proteas
inhibitor
effect
agent
facilit
combinatori
synthesi
deriv
improv
inhibitori
activ
reagent
commerci
avail
use
without
purif
unless
indic
otherwis
solvent
anhydr
grade
unless
indic
otherwis
nonaqu
reaction
carri
ovendri
glasswar
slight
posit
pressur
argon
unless
otherwis
note
reaction
mixtur
magnet
stir
monitor
thinlay
chromatographi
silica
gel
flash
chromatographi
perform
silica
gel
lm
particl
size
yield
report
spectroscop
pure
compound
melt
point
record
electrotherm
meltemp
melt
point
apparatu
nmr
spectra
record
bruker
avanc
spectromet
chemic
shift
given
valu
rel
tetramethylsilan
tm
coupl
constant
j
given
hz
intern
standard
cdcl
h
dmsod
h
hnmr
spectra
cdcl
c
dmsod
c
cnmr
spectra
split
pattern
report
singlet
doublet
triplet
q
quartet
multiplet
br
broad
dd
doubl
doublet
ir
spectra
record
thermo
nicolet
ftir
spectromet
high
resolut
esi
mass
spectra
record
bruker
dalton
spectromet
gene
encod
proteas
clone
viral
cdna
obtain
changgung
memori
hospit
taoyuan
taiwan
use
polymeras
chain
reaction
pcr
forward
primer
catgccatggcatcatcatcatcatcatggccgagcttgga
backward
primer
gcgctcgagtcattgttcact
purif
histag
proteas
conduct
cell
past
obtain
l
cell
cultur
suspend
ml
lysi
buffer
contain
mm
trishcl
ph
mm
nacl
frenchpress
instrument
aimaminco
spectron
instrument
use
disrupt
cell
psi
lysi
solut
centrifug
debri
discard
cellfre
extract
load
onto
ninta
column
equilibr
mm
trishcl
ph
mm
nacl
mm
imidazol
column
wash
mm
imidazol
follow
mm
imidazolecontain
buffer
histag
proteas
elut
mm
trishcl
ph
mm
nacl
mm
imidazol
protein
solut
dialyz
l
buffer
contain
mm
trishcl
ph
mm
nacl
mm
edta
mm
bmercaptoethanol
mm
dtt
purifi
protein
confirm
ntermin
sequenc
mass
spectrometri
protein
concentr
use
experi
determin
absorb
nm
prepar
untag
protein
sp
sepharos
cation
exchang
column
appli
purifi
proteas
untag
protein
elut
linear
gradient
nacl
mm
subsequ
elut
sampl
subject
sizeexclus
chromatographi
sephadex
gl
column
purif
peptid
test
proteas
substrat
synthes
via
solid
phase
use
peptid
synthes
appli
biosystem
usa
start
mmol
g
phydroxymethyl
phenoxymethyl
polystyren
resin
mmolg
synthesi
perform
use
stepwis
fastmoc
protocol
appli
biosystem
usa
amino
acid
introduc
use
manufactur
prepack
cartridg
mmol
examin
substrat
specif
proteas
peptid
lm
incub
lm
proteas
h
result
mixtur
inject
reversephas
hplc
analysi
use
abovement
condit
area
product
peak
integr
calcul
reaction
rate
peptid
substrat
catalysi
proteas
best
peptid
substrat
attach
fluoresc
quench
pair
fluorogen
peptid
dabcylktsavlq
sgfrkmeedan
use
measur
proteas
activ
kinet
constant
fluorogen
peptid
measur
mm
me
ph
optim
ph
proteas
enhanc
fluoresc
due
cleavag
peptid
monitor
nm
excit
nm
use
fluoresc
plate
reader
fluoroskan
ascent
thermolabsystem
finland
enzym
concentr
use
measur
k
k
cat
valu
lm
substrat
concentr
estim
k
valu
substrat
concentr
determin
use
extinct
coeffici
cm
nm
edan
cm
nm
dabcyl
initi
rate
within
substrat
consumpt
differ
substrat
concentr
use
calcul
kinet
paramet
use
michaelismenten
equat
fit
kaleidagraph
comput
program
known
compound
prepar
previous
report
synthesi
new
compound
describ
detail
solut
hcl
ml
ad
solut
mg
mmol
ml
room
temperatur
mixtur
stir
h
concentr
reduc
pressur
give
crude
ammonium
salt
materi
boclph
mg
mmol
dissolv
dmf
ml
cool
follow
addit
n
ndiisopropylethylamin
ml
mmol
hobt
mg
mmol
edci
mg
mmol
mixtur
remov
ice
bath
stir
h
room
temperatur
dilut
ch
cl
ml
mixtur
wash
aqueou
citric
acid
ml
water
ml
brine
ml
organ
phase
dri
na
filtrat
concentr
residu
oil
purifi
flash
column
chromatographi
etoachexan
afford
desir
product
mg
two
step
ice
cool
suspens
methylenedioxi
cinnam
acid
mg
mmol
thf
ml
pcl
mg
mmol
ad
mixtur
stir
min
min
room
temperatur
prepar
acid
chlorid
solut
solut
hcl
ml
ad
solut
mg
mmol
ml
room
temperatur
mixtur
stir
h
concentr
reduc
pressur
yield
crude
ammonium
salt
materi
dissolv
thf
ml
dmf
ml
cool
acid
chlorid
solut
nmethylmorpholin
ml
mmol
ad
sequenti
ice
bath
remov
stir
h
room
temperatur
reaction
mixtur
partit
ch
cl
ml
water
ml
organ
layer
wash
water
ml
brine
ml
dri
na
filtrat
concentr
solut
hcl
ml
ad
solut
mg
mmol
ml
room
temperatur
mixtur
stir
h
concentr
reduc
pressur
yield
crude
ammonium
salt
materi
cbzlphe
mg
mmol
dissolv
dmf
ml
cool
follow
addit
n
ndiisopropylethylamin
ml
mmol
hobt
mg
mmol
edci
mg
mmol
mixtur
remov
ice
bath
stir
h
room
temperatur
dilut
ch
cl
ml
mixtur
wash
aqueou
citric
acid
ml
water
ml
brine
ml
organ
phase
dri
na
filtrat
concentr
residu
oil
purifi
flash
column
chromatographi
etoachexan
afford
desir
product
mg
two
step
compound
mg
mmol
dissolv
ch
cl
ml
libh
solut
thf
ml
mmol
ad
solut
reaction
mixtur
stir
h
reaction
quench
ad
satur
nh
cl
solut
ml
volatil
remov
reduc
pressur
aqueou
residu
extract
ch
cl
ml
combin
organ
layer
wash
brine
dri
mgso
filtrat
concentr
crude
product
mg
use
next
step
without
purif
alcohol
mg
dissolv
ch
cl
ml
treat
dessmartin
periodinan
mg
mmol
reaction
mixtur
warm
room
temperatur
stir
continu
h
reaction
quench
mixtur
na
g
aqueou
satur
nahco
ml
result
mixtur
stir
organ
layer
turn
clear
organ
layer
separ
aqueou
layer
extract
ch
cl
ml
combin
organ
layer
dri
na
filtrat
concentr
residu
purifi
flash
column
chromatographi
meohch
solut
g
mmol
carbethoxymethylen
triphenylphosphoran
g
mmol
toluen
ml
reflux
h
concentr
reduc
pressur
give
crude
product
residu
solid
purifi
flash
column
chromatographi
etoachexan
afford
bunsatur
ethyl
ester
bunsatur
ethyl
ester
g
mmol
dissolv
thf
ml
ad
aqueou
lioh
n
ml
mmol
reaction
mixtur
stir
h
room
temperatur
aqueou
citric
acid
ad
make
ph
mixtur
extract
etoac
ml
combin
organ
layer
wash
brine
organ
layer
dri
mgso
filtrat
concentr
reduc
pressur
residu
solid
g
use
directli
without
purif
colorless
solid
mp
h
nmr
dmsod
ice
cool
suspens
methylenedioxi
cinnam
acid
mg
mmol
thf
ml
pcl
mg
mmol
ad
mixtur
stir
min
min
room
temperatur
prepar
acid
chlorid
solut
compound
mg
mmol
ch
oh
ml
treat
pdc
mg
put
hydrogen
atmospher
room
temperatur
h
catalyst
remov
filtrat
celit
follow
wash
ch
oh
filtrat
concentr
vacuo
afford
deprotect
amin
product
mg
materi
dissolv
thf
ml
dmf
ml
cool
acid
chlorid
solut
nmethylmorpholin
ml
mmol
ad
sequenti
ice
bath
remov
stir
h
room
temperatur
reaction
mixtur
partit
ch
cl
ml
water
ml
organ
layer
wash
water
ml
brine
ml
dri
na
filtrat
concentr
residu
purifi
flash
column
chromatographi
meohch
cl
provid
mg
ic
measur
reaction
perform
lm
proteas
lm
fluorogen
peptid
buffer
mm
me
ph
fluoresc
chang
result
reaction
follow
time
use
fluoresc
plate
reader
initi
veloc
enzymat
reaction
first
min
reaction
plot
differ
inhibitor
concentr
obtain
ic
fit
eq
eq
enzym
activ
inhibitor
concentr
enzym
activ
without
inhibitor
inhibitor
concentr
k
measur
timedepend
inhibit
lm
inhibitor
use
inhibit
lm
enzym
reduct
enzym
activ
incub
time
enzym
inhibitor
fit
singl
exponenti
equat
obtain
k
ob
inactiv
differ
inhibitor
concentr
k
ob
inactiv
halflif
calcul
ob
halflif
inactiv
inactiv
concentr
plot
inactiv
yield
line
intersect
yaxi
ln
inact
valu
k
inact
determin
extrapol
neg
xaxi
intercept
assay
measur
abil
test
compound
prevent
infect
human
embryon
rhabdomyosarcoma
cell
rd
cell
tissu
cultur
plate
seed
rd
cell
concentr
cellsml
dulbecco
modifi
eagl
medium
dmem
fetal
bovin
serum
fb
plate
incub
h
use
confluenc
viru
tcid
mix
differ
concentr
test
compound
ad
cell
incub
h
adsorpt
infect
cell
plate
overlaid
dmem
plu
fb
dmso
plate
incub
h
end
incub
plate
fix
addit
formaldehyd
h
room
temperatur
remov
formaldehyd
plate
stain
crystal
violet
min
room
temperatur
plate
wash
dri
densiti
remain
cell
well
measur
nm
concentr
requir
test
compound
reduc
virusinduc
cell
death
rel
viru
control
defin
ec
assay
perform
triplic
least
twice
abil
inhibit
viral
protein
accumul
perform
use
rd
cell
grown
dmem
supplement
fetal
calf
serum
confluent
cell
plate
infect
multipl
infect
moi
absenc
presenc
lm
h
post
infect
total
cell
lysat
harvest
subject
sdspage
protein
sampl
subsequ
transfer
pvdf
membran
probe
mous
monoclon
antibodi
proteas
antibactin
antibodi
rabbit
antimous
antibodi
conjug
horseradish
peroxidas
amersham
bioscienc
use
secondari
antibodi
horseradish
peroxidas
detect
enhanc
chemiluminesc
detect
system
ecl
amersham
pharmacia
freiburg
germani
construct
proteas
structur
model
base
xray
crystal
structur
rv
proteas
bound
pdb
code
templat
use
softwar
discoveri
studio
accelri
inc
dock
activ
site
perform
autom
liganddock
program
discoveri
studio
dock
util
genet
algorithm
set
paramet
control
precis
oper
via
defin
bind
site
specifi
ligand
conform
energi
grid
paramet
variabl
number
mont
carol
trial
select
score
type
